I-SPY Trial

The I-SPY Trial is a research initiative designed to improve treatments for children with high-risk neuroblastoma, a type of cancer that primarily affects young children. It aims to identify effective therapies based on individual tumor characteristics. By testing new drugs in various combinations, the trial seeks to determine which treatments work best for specific genetic profiles of the tumors. This personalized approach helps doctors tailor therapy to each child's needs, potentially increasing their chances of recovery and minimizing side effects. The I-SPY Trial ultimately strives to enhance survival rates and the quality of life for affected children.